Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
1.
Biomolecules ; 14(3)2024 Mar 16.
Article in English | MEDLINE | ID: mdl-38540774

ABSTRACT

In all mammals, the circulating pool of MLTs is synthesized in the pineal gland during the night's darkness hours. Its main function is synchronizing the organism in the photoperiod. In contrast, extra-pineal MLT is synthesized in peripheral organs, does not follow any circadian rhythm or circulate, and plays a detoxifying and cytoprotective role. Circulating MLT may stimulate both innate and acquired immune responses through its circadian action and by activating high-affinity receptors on immunocompetent cells. Extra-pineal MLT may have antioxidant and anti-inflammatory effects that dampen the innate immune response. These two seemingly divergent roles may be considered to be two sides of the same coin. In fact, the integration of both circulating and extra-pineal MLT functions might generate a balanced and effective immune response against microbial pathogens. The studies described in this review investigated the effects of exogenous MLT in various models of infectious diseases using extremely different doses and treatment schedules. None of them evaluated the possibility of integrating the non-circadian anti-inflammatory effect with the circadian immunoenhancing action of MLT. As a consequence, in spite of the fact that most studies agree that MLT has a beneficial effect against infections, it seems difficult to draw any definite conclusion about its possible therapeutic use.


Subject(s)
Melatonin , Parasitic Diseases , Pineal Gland , Animals , Humans , Melatonin/therapeutic use , Pineal Gland/physiology , Antioxidants/pharmacology , Circadian Rhythm , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Mammals
2.
J Am Chem Soc ; 146(4): 2673-2684, 2024 Jan 31.
Article in English | MEDLINE | ID: mdl-38238037

ABSTRACT

The revalorization of incompatible polymer blends is a key obstacle in realizing a circular economy in the plastics industry. Polyolefin waste is particularly challenging because it is difficult to sort into its constituent components. Untreated blends of polyethylene and polypropylene typically exhibit poor mechanical properties that are suitable only for low-value applications. Herein, we disclose a simple azidotriazine-based grafting agent that enables polyolefin blends to be directly upcycled into high-performance materials by using reactive extrusion at industrially relevant processing temperatures. Based on a series of model experiments, the azidotriazine thermally decomposes to form a triplet nitrene species, which subsequently undergoes a complex mixture of grafting, oligomerization, and cross-linking reactions; strikingly, the oligomerization and cross-linking reactions proceed through the formation of nitrogen-nitrogen bonds. When applied to polyolefin blends during reactive extrusion, this combination of reactions leads to the generation of amorphous, phase-separated nanostructures that tend to exist at polymer-polymer interfaces. These nanostructures act as multivalent cross-linkers that reinforce the resulting material, leading to dramatically improved ductility compared with the untreated blends, along with high dimensional stability at high temperatures and excellent mechanical recyclability. We propose that this unique behavior is derived from the thermomechanically activated reversibility of the nitrogen-nitrogen bonds that make up the cross-linking structures. Finally, the scope of this chemistry is demonstrated by applying it to ternary polyolefin blends as well as postconsumer polyolefin feedstocks.

3.
J Am Chem Soc ; 144(1): 410-415, 2022 01 12.
Article in English | MEDLINE | ID: mdl-34932352

ABSTRACT

Narcissistic self-sorting in supramolecular assemblies can help to construct materials with more complex hierarchies. Whereas controlled changes in pH or temperature have been used to this extent for two-component self-sorted gels, here we show that a chemically fueled approach can provide three-component materials with high precision. The latter materials have interesting mechanical properties, such as enhanced or suppressed stiffness, and intricate multistep gelation kinetics. In addition, we show that we can achieve supramolecular templating, where pre-existing supramolecular fibers first act as templates for growth of a second gelator, after which they can selectively be removed.

4.
J Am Chem Soc ; 143(31): 11914-11918, 2021 08 11.
Article in English | MEDLINE | ID: mdl-34342435

ABSTRACT

Controlling supramolecular polymerization is of fundamental importance to create advanced materials and devices. Here we show that the thermodynamic equilibrium of Gd3+-bearing supramolecular rod networks is shifted reversibly at room temperature in a static magnetic field of up to 2 T. Our approach opens opportunities to control the structure formation of other supramolecular or coordination polymers that contain paramagnetic ions.

5.
J Am Chem Soc ; 142(9): 4083-4087, 2020 03 04.
Article in English | MEDLINE | ID: mdl-32065526

ABSTRACT

Nature uses catalysis as an indispensable tool to control assembly and reaction cycles in vital non-equilibrium supramolecular processes. For instance, enzymatic methionine oxidation regulates actin (dis-)assembly, and catalytic guanosine triphosphate hydrolysis is found in tubulin (dis-)assembly. Here we present a completely artificial reaction cycle which is driven by a chemical fuel that is catalytically obtained from a "pre-fuel". The reaction cycle controls the dis-assembly and re-assembly of a hydrogel, where the rate of pre-fuel turnover dictates the morphology as well as the mechanical properties. By addition of additional fresh aliquots of fuel and removal of waste, the hydrogels can be re-programmed time after time. Overall, we show how catalytic fuel generation can control reaction/assembly kinetics and materials' properties in life-like non-equilibrium systems.

6.
Adv Mater ; 32(20): e1906834, 2020 May.
Article in English | MEDLINE | ID: mdl-32064688

ABSTRACT

Fuel-driven reaction cycles are found in biological systems to control the assembly and disassembly of supramolecular materials such as the cytoskeleton. Fuel molecules can bind noncovalently to a self-assembling building block or they can react with it, resulting in covalent modifications. Overall the fuel can either switch the self-assembly process on or off. Here, a closer look is taken at artificial systems that mimic biological systems by making and breaking covalent bonds in a self-assembling motif. The different chemistries used so far are highlighted in chronological order and the pros and cons of each system are discussed. Moreover, the desired traits of future reaction cycles, their fuels, and waste management are outlined, and two chemistries that have not been explored up to now in chemically fueled dissipative self-assembly are suggested.

7.
J Neuroimmune Pharmacol ; 15(1): 82-92, 2020 03.
Article in English | MEDLINE | ID: mdl-30762159

ABSTRACT

Hematopoiesis produce every day billions of blood cells and takes place in the bone marrow (BM) by the proliferation and differentiation of hematopoietic stem cells (HSC). HSC are found mainly adjacent to the BM vascular sinusoids where endothelial cells and mesenchimal stromal cells promote HSC maintenance by producing a variety of factors. Other cell types that regulate HSC niches include sympathetic nerves, non-myelinating Schwann cells and a variety of mature hematopoietic cells such as macrophages, neutrophils, and megakaryocytes. This review will focus on the role of adrenergic signals, i.e. of catecholamines, in the regulation of the HSC niche. The available evidence is rather controversial possibly due to the fact that adrenergic receptors are expressed by many cellular components of the niche and also by the often neglected observation that catecholamines may be produced and released also by the BM cells themselves. In addition one has to consider that, physiologically, the sympathetic nervous system (SNS) activity follows a circadian rhythmicity as driven by the suprachiasmatic nucleus (SCN) of the hypothalamus but may be also activated by cognitive and non-cognitive environmental stimuli. The adrenergic modulation of hematopoiesis holds a considerable potential for pharmacological therapeutic approaches in a variety of hematopoietic disorders and for HSC transplantation however the complexity of the system demands further studies. Graphical Abstract Sympathetic nerve termini may release NE while mature BM cells may release norepinephrine (NE) and / or epinephrine (E). Both may bind to ß-adrenergic receptor (AR) expressed in nestin+MSC in the hematopoietic stem cell (HSC) niche and regulate the physiological trafficking of HSC by modulating the expression of CXCL12 and SCF. Both NE and E may also activate Lin - c-Kit+ Sca-1+ (LKS) cell via another AR. In addition, NE may also signal to α1-AR expressed in pre-B cells which by TGF-ß secretion might regulate proliferation of their lymphoid progenitors in an autocrine manner and/or inhibit myeloid progenitors.


Subject(s)
Adrenergic Agents/metabolism , Hematopoiesis/physiology , Hematopoietic Stem Cells/metabolism , Receptors, Adrenergic, beta/metabolism , Adrenergic Agents/immunology , Adrenergic Fibers/drug effects , Adrenergic Fibers/immunology , Adrenergic Fibers/metabolism , Adrenergic beta-Agonists/immunology , Adrenergic beta-Agonists/metabolism , Adrenergic beta-Antagonists/immunology , Adrenergic beta-Antagonists/metabolism , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Epinephrine/immunology , Epinephrine/metabolism , Hematopoiesis/drug effects , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/immunology , Humans , Norepinephrine/immunology , Norepinephrine/metabolism , Receptors, Adrenergic, beta/immunology
8.
Angew Chem Int Ed Engl ; 57(35): 11349-11353, 2018 08 27.
Article in English | MEDLINE | ID: mdl-29999232

ABSTRACT

Controlling supramolecular growth at solid surfaces is of great importance to expand the scope of supramolecular materials. A dendritic benzene-1,3,5-tricarboxamide peptide conjugate is described in which assembly can be triggered by a pH jump. Stopped-flow kinetics and mathematical modeling provide a quantitative understanding of the nucleation, elongation, and fragmentation behavior in solution. To assemble the molecule at a solid-liquid interface, we use proton diffusion from the bulk. The latter needs to be slower than the lag phase of nucleation to progressively grow a hydrogel outwards from the surface. Our method of surface-assisted self-assembly is generally applicable to other gelators, and can be used to create structured supramolecular materials.

9.
Front Cell Neurosci ; 9: 302, 2015.
Article in English | MEDLINE | ID: mdl-26300737

ABSTRACT

Innervation of the bone marrow (BM) has been described more than one century ago, however the first in vivo evidence that sympathoadrenergic fibers have a role in hematopoiesis dates back to less than 25 years ago. Evidence has since increased showing that adrenergic nerves in the BM release noradrenaline and possibly also dopamine, which act on adrenoceptors and dopaminergic receptors (DR) expressed on hematopoietic cells and affect cell survival, proliferation, migration and engraftment ability. Remarkably, dysregulation of adrenergic fibers to the BM is associated with hematopoietic disturbances and myeloproliferative disease. Several adrenergic and dopaminergic agents are already in clinical use for non-hematological indications and with a usually favorable risk-benefit profile, and are therefore potential candidates for non-conventional modulation of hematopoiesis.

10.
Prog Neurobiol ; 85(3): 335-53, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18571301

ABSTRACT

Melatonin, an endogenous signal of darkness, is an important component of the body's internal time-keeping system. As such it regulates major physiological processes including the sleep wake cycle, pubertal development and seasonal adaptation. In addition to its relevant antioxidant activity, melatonin exerts many of its physiological actions by interacting with membrane MT1 and MT2 receptors and intracellular proteins such as quinone reductase 2, calmodulin, calreticulin and tubulin. Here we review the current knowledge about the properties and signaling of melatonin receptors as well as their potential role in health and some diseases. Melatonin MT1 and MT2 receptors are G protein coupled receptors which are expressed in various parts of the CNS (suprachiasmatic nuclei, hippocampus, cerebellar cortex, prefrontal cortex, basal ganglia, substantia nigra, ventral tegmental area, nucleus accumbens and retinal horizontal, amacrine and ganglion cells) and in peripheral organs (blood vessels, mammary gland, gastrointestinal tract, liver, kidney and bladder, ovary, testis, prostate, skin and the immune system). Melatonin receptors mediate a plethora of intracellular effects depending on the cellular milieu. These effects comprise changes in intracellular cyclic nucleotides (cAMP, cGMP) and calcium levels, activation of certain protein kinase C subtypes, intracellular localization of steroid hormone receptors and regulation of G protein signaling proteins. There are circadian variations in melatonin receptors and responses. Alterations in melatonin receptor expression as well as changes in endogenous melatonin production have been shown in circadian rhythm sleep disorders, Alzheimer's and Parkinson's diseases, glaucoma, depressive disorder, breast and prostate cancer, hepatoma and melanoma. This paper reviews the evidence concerning melatonin receptors and signal transduction pathways in various organs. It further considers their relevance to circadian physiology and pathogenesis of certain human diseases, with a focus on the brain, the cardiovascular and immune systems, and cancer.


Subject(s)
Melatonin/physiology , Receptors, Melatonin/physiology , Signal Transduction/physiology , Animals , Humans
11.
J Immunother ; 31(3): 263-70, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18317361

ABSTRACT

The aim of the present study was to evaluate the role of beta2-adrenergic receptors (beta2-ARs) in the outcome of a dendritic cell (DC)-based cancer vaccine in the murine E.G7-ovalbumin (OVA) model. We found that unlike the beta2-AR expressed on antigen loaded DCs, beta2-ARs expressed in the site of DCs inoculation may influence the efficacy of the antitumor response. Intradermal injection of Staphylococcus aureus peptidoglycan along with the beta2-AR-specific antagonist ICI 118,551 increased the local innate cytokine response in tumor-bearing mice. When the adoptive transfer of immature DCs loaded with OVA followed this skin preconditioning, the antitumor response was increased and tumor growth was significantly reduced. Surprisingly, when OVA-loaded mature DCs were used, the effect of the skin preconditioning was the opposite and tumor growth was similar to that observed in control, nonimmunized mice. The extent of the antitumor response on transfer of immature or mature DCs was mediated by a different migration in the draining lymph nodes and by a distinct recruitment of endogenous DCs that resulted in a modulation of the OVA-specific cytotoxic T lymphocyte response. The unexpected tolerogenic effect exerted by mature DCs on skin preconditioning was apparently mediated by the expression of a distinctive pattern of cytokines and of the suppressive enzyme indoleamine 2, 3-dioxygenase in draining lymph nodes. In conclusion, we found that beta2-ARs inhibition along with toll-like receptor2 activation at the site of cancer vaccination may either enhance the resulting antitumor response or be tolerogenic in dependence of the maturation state of the transferred DCs.


Subject(s)
Antigen Presentation , Cancer Vaccines/immunology , Cytotoxicity, Immunologic , Dendritic Cells/immunology , Neoplasms, Experimental/immunology , Receptors, Adrenergic, beta-2/immunology , Administration, Cutaneous , Adrenergic beta-2 Receptor Antagonists , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/immunology , Albuterol/administration & dosage , Albuterol/immunology , Animals , Antigen Presentation/drug effects , Antigens, Neoplasm/immunology , Cancer Vaccines/administration & dosage , Cell Differentiation , Cell Line, Tumor , Cytotoxicity Tests, Immunologic , Cytotoxicity, Immunologic/drug effects , Gene Expression Profiling , Indoleamine-Pyrrole 2,3,-Dioxygenase/administration & dosage , Indoleamine-Pyrrole 2,3,-Dioxygenase/immunology , Mice , Mice, Inbred C57BL , Neoplasm Transplantation , Neoplasms, Experimental/prevention & control , Peptidoglycan/administration & dosage , Peptidoglycan/immunology , Propanolamines/administration & dosage , Propanolamines/immunology , Skin/immunology , Vaccination/methods
12.
Brain Behav Immun ; 22(1): 80-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17716858

ABSTRACT

Disorders of the skin immune activity are implicated in the pathogenesis of acquired inflammatory skin disorders. Inflammatory diseases including psoriasis, atopic dermatitis, lichen planus and vitiligo have also been associated with local alterations of adrenergic mechanisms and emotional stress. Here we show that the beta-adrenergic receptors antagonist propranolol along with peptidoglycan, but not LPS, combined with intradermal injection of a soluble protein, shifted the recall memory response to the Th1 type. The specific beta2-AR antagonist ICI 118,551 did not reproduce this effect suggesting that inhibition of both beta1- and beta2-AR caused the Th1 polarization. The underlying mechanism included enhanced local expression of IFN-gamma, IL-12 and IL-23 as well as of IFN-beta and CXCR3 ligands during the innate phase of the response which resulted in an increase of antigen-positive plasmacytoid dendritic cells (pDCs) in the draining lymph node. In particular, modulation of inflammatory cytokines, and IFN-beta inducible genes expression appeared to involve also the beta1-AR. Plasmacytoid dendritic cells and IL-23 were recently reported to play a central role in the pathogenesis of Th1-sustained inflammatory skin diseases such as psoriasis. Thus, primary beta-adrenoceptors signaling defects or altered sympathetic nervous activity together with selected pattern recognition receptors activation might serve as initiation and/or persistence factors for numerous Th1-sustained inflammatory skin diseases.


Subject(s)
Adaptation, Physiological , Immunity, Innate , Lipopolysaccharides/immunology , Peptidoglycan/immunology , Skin/immunology , Sympathetic Nervous System/physiology , Adrenergic beta-Antagonists/pharmacology , Animals , Betaxolol/pharmacology , Cell Movement/drug effects , Dendritic Cells/drug effects , Dendritic Cells/immunology , Female , Immunity, Innate/drug effects , Immunization , Immunologic Memory/drug effects , Inflammation/immunology , Injections, Intradermal , Interferon-beta/metabolism , Ligands , Lipopolysaccharides/administration & dosage , Mice , Mice, Inbred BALB C , Mice, Transgenic , Ovalbumin/immunology , Peptidoglycan/administration & dosage , Peptidoglycan/pharmacology , Propanolamines/pharmacology , Propranolol/pharmacology , Receptors, Adrenergic, beta/metabolism , Receptors, CXCR3/metabolism , Skin/cytology , Skin/metabolism , Skin Diseases/immunology , Th1 Cells/immunology
13.
Ann N Y Acad Sci ; 1069: 195-207, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16855146

ABSTRACT

Our studies focused on the sympathetic nervous system (SNS) influence on dendritic cells (DCs), which play a crucial role in the innate immune response. We found that DCs express a variety of adrenergic receptors (ARs) with alpha1-ARs playing a stimulatory and beta2-ARs an inhibitory effect on DCs migration. beta2-ARs in skin and bone marrow-derived DCs when stimulated by bacterial toll-like receptors (TLRs) agonists respond to norepinephrine (NE) by decreased interleukin-12 (IL-12) and increased IL-10 production which in turn downregulates inflammatory cytokine production and CCR7 expression and thus their migration ability leading to reduced T helper-1 (Th1) priming. We also found that contact sensitizers that may induce a predominant Th1 response, do so by inhibiting the local NE turnover in the skin. The SNS seems therefore to contribute in shaping the information conveyed by DCs to T cells and thus in inducing the appropriate adaptive immune response. In this sense, the SNS physiological influence may allow Th2 priming to fight infections sustained by extracellular pathogens and limit the risk for organ-specific autoimmune reactions associated with excessive Th1 priming and inhibition of T regulatory cell functions. More recently, we found that preconditioning of the skin by beta-adrenergic antagonist and the TLR2 agonist S. Aureus peptidoglycan (PGN) may instruct a Th1 adaptive response to a soluble protein antigen. On the contrary, when the TLR4 agonist E. Coli lipopolysaccharide was used, the presence of the beta-adrenergic antagonist was not effective. These effects were consonant with the pattern of TLRs expression shown by epidermal keratinocytes (EKs) but not by skin DCs. As beta-ARs signaling defects together with S. Aureus infections are thought to serve as initiation and/or persistence factors for numerous Th1-sustained autoimmune inflammatory skin diseases, we might have disclosed at least part of the relevant pathogenetic mechanism.


Subject(s)
Immunity, Innate/immunology , Sympathetic Nervous System/physiology , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Humans , Receptors, Interleukin-2/immunology , Receptors, Interleukin-2/metabolism , Skin/immunology
14.
Int J Exp Pathol ; 87(2): 81-7, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16623752

ABSTRACT

Melatonin, a neurohormone produced mainly by the pineal gland, is a modulator of haemopoiesis and of immune cell production and function, both in vivo and in vitro. Physiologically, melatonin is associated with T-helper 1 (Th1) cytokines, and its administration favours Th1 priming. In both normal and leukaemic mice, melatonin administration results in quantitative and functional enhancement of natural killer (NK) cells, whose role is to mediate defenses against virus-infected and cancer cells. Melatonin appears to regulate cell dynamics, including the proliferative and maturational stages of virtually all haemopoietic and immune cells lineages involved in host defense - not only NK cells but also T and B lymphocytes, granulocytes and monocytes - in both bone marrow and tissues. In particular, melatonin is a powerful antiapoptotic signal promoting the survival of normal granulocytes and B lymphocytes. In mice bearing mid-stage leukaemia, daily administration of melatonin results in a survival index of 30-40% vs. 0% in untreated mice. Thus, melatonin seems to have a fundamental role as a system regulator in haemopoiesis and immuno-enhancement, appears to be closely involved in several fundamental aspects of host defense and has the potential to be useful as an adjuvant tumour immunotherapeutic agent.


Subject(s)
Melatonin/immunology , Neoplasms/immunology , Animals , Apoptosis/immunology , B-Lymphocytes/immunology , Cytokines/immunology , Hematopoiesis/immunology , Humans , Immunotherapy/methods , Killer Cells, Natural/immunology , Melatonin/therapeutic use , Mice , Neoplasms/therapy , T-Lymphocytes/immunology
15.
Curr Neurovasc Res ; 2(2): 169-73, 2005 Apr.
Article in English | MEDLINE | ID: mdl-16181110

ABSTRACT

Dendritic cells (DC) play a key role in determining the appropriate immune response to invading pathogens and tolerance to self antigens. Here I review the evidence that dendritic cell functions may be tuned by the sympathetic nervous system via the local release of norepinephrine. In the presence of antigens or microbial products, such as agonists for Toll-like receptors 2 and 4, norepinephrine inhibits dendritic cell migration, antigen presentation and T-helper cells type 1 priming. This effect, which is mainly mediated by beta-adrenergic receptors in DC and interlukin-10 production, limits potentially damaging reactions and is functional in shaping the appropriate humoral immune response to extracellular pathogens that need antibodies to be neutralized. In addition, the response to contact sensitizers seems to involve a modulation of the local sympathetic activity. Thus, the sympathetic nervous system may play a crucial role in modulating DC function during the innate phase of the immune response. This evidence has many pathophysiological implications and offers new tools for modulating the immune response.


Subject(s)
Dendritic Cells/immunology , Homeostasis/physiology , Immune System/physiology , Sympathetic Nervous System/physiology , Animals , Humans
16.
J Neuroimmunol ; 158(1-2): 106-11, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15589043

ABSTRACT

The pineal neurohormone melatonin (MLT) has been widely shown to exert an immunostimulatory and antiapoptotic role, mainly by acting on Th cells and on T and B cell precursors, respectively. Thus, MLT might favor or promote autoimmune diseases by acting directly on immature and mature immunocompetent cells. In fact, preclinical and clinical evidence point to a disease-promoting role of MLT in rheumatoid arthritis (RA). MLT, whose concentration is increased in serum from RA patients, may act systemically or locally in the inflamed joints. The circadian secretion of MLT with a peak level during the night hours might be strictly correlated with the peculiar daily rhythmicity of the RA symptoms. In rat studies employing Freund's complete mycobacterial adjuvant (FCA) as a model of rheumatoid arthritis, pinealectomized rats turned arthritic and exhibited a significantly less pronounced inflammatory response, which was restored to normal by a low MLT dose and was aggravated by a pharmacological MLT dose, that augmented the inflammatory and immune response. Continued investigation will refine our understanding of these observations, which will possibly translate into improved therapeutic approaches.


Subject(s)
Arthritis, Rheumatoid/physiopathology , Melatonin/physiology , Animals , Arthritis, Rheumatoid/metabolism , Disease Models, Animal , Humans , Melatonin/blood , Periodicity
17.
FASEB J ; 18(15): 1914-6, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15385435

ABSTRACT

The decision-making mechanisms that determine the choice of the appropriate effector immune response to a microbial challenge are poorly understood. The endocannabinoid 2-arachidonoylglycerol (2-AG), injected intradermally in mice together with a soluble protein and a T helper-2 (Th2) priming Toll-like receptors (TLRs) agonist during primary immunization, shifts the memory response to the Th1 type. This effect can be shown by the enhanced hypersensitivity response and by the Th1 pattern of cytokines production that was abolished by the specific cannabinoid receptor CB2 antagonist SR 144528. 2-AG seems to operate during the innate response by increasing the number of dendritic cells (DCs) migrating to the draining lymph nodes. Expression of CB2 mRNA but not of the protein was higher in immature vs. mature DCs. Consistently, in vitro, 2-AG exerted a potent chemotactic activity on both immature and mature DCs. In conclusion, we suggest that, in vivo, the endocannabinoid 2-AG may act as chemotactic substance capable of recruiting DCs and/or their precursors during the innate immune response that, in presence of a TLR agonist, consequently instruct a Th1-shifted adaptive response. As 2-AG may be induced in tissues by various stimuli at concentrations similar to that used in our study, this evidence might be of a wide-ranging pathophysiological relevance.


Subject(s)
Adjuvants, Immunologic/pharmacology , Arachidonic Acids/pharmacology , Cannabinoid Receptor Modulators/pharmacology , Chemotactic Factors/pharmacology , Dendritic Cells/immunology , Glycerides/pharmacology , Th1 Cells/immunology , Animals , Dendritic Cells/drug effects , Endocannabinoids , Immunologic Memory , Mice , Proteins/immunology , Receptor, Cannabinoid, CB2/metabolism
18.
J Invest Dermatol ; 122(1): 119-24, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14962099

ABSTRACT

The information gathered by dendritic cells during the innate immune response is determinant for the type and strength of the adaptive response. We showed that the sympathetic neurotransmitter norepinephrine influences dendritic cell migration and T helper priming via alpha- and beta-adrenoceptors. Others have shown that Langerhans cells also express mRNA for beta 1-, beta 2-, and alpha 1A-adrenoceptors and that catecholamines may inhibit the antigen-presenting capability via beta 2-adrenoceptors. Here we report that oxazolone, which induces a predominant T-helper-1-type contact hypersensitivity response, but not fluorescein isothiocyanate, which induces a prevailing T-helper-2-type response, inhibits the local norepinephrine turnover in the skin of mice during the first 8 h of sensitization. Oxazolone also induced higher expression of the inflammatory cytokines interleukin-1 and interleukin-6 mRNA in the skin. Lack or blockade of these cytokines as well as inhibition of prostaglandin synthesis, however, did not influence the oxazolone effect. Only the nonspecific anti-inflammatory steroid dexamethasone could neutralize the effect of oxazolone. Furthermore, fluorescein isothiocyanate but not oxazolone sensitization in the presence of the specific beta 2-adrenoceptor antagonist ICI 118,551 enhanced the consequent contact hypersensitivity response as well as the production of T helper 1 cytokines in draining lymph nodes; conversely T helper 2 cytokines were not affected. Thus, the extent of T helper 1 priming in the adaptive response to a sensitizing agent seems to depend also on its ability to modulate the local sympathetic nervous activity during the innate immune response.


Subject(s)
Dermatitis, Contact/immunology , Dermatitis, Contact/metabolism , Norepinephrine/metabolism , Skin/immunology , Skin/innervation , Adjuvants, Immunologic/pharmacology , Adrenergic beta-2 Receptor Antagonists , Adrenergic beta-Antagonists/pharmacology , Allergens/immunology , Animals , Female , Gene Expression/drug effects , Gene Expression/immunology , Interleukin-1/genetics , Interleukin-6/genetics , Langerhans Cells/immunology , Mice , Mice, Inbred BALB C , Oxazolone/pharmacology , Propanolamines/pharmacology , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/immunology , Sympathetic Nervous System/metabolism , Th1 Cells/immunology , Th2 Cells/immunology
19.
J Neuroimmunol ; 144(1-2): 91-9, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14597102

ABSTRACT

We showed that norepinephrine (NE) hampers IL-12 and stimulates IL-10 production via adrenoceptors (ARs) in bone marrow-derived dendritic cells (BMDC) influencing their Th priming ability. Others have shown that Langerhans cells (LC) express mRNA for beta1-, beta2- and alpha1(A)-(ARs) and that catecholamines may inhibit the antigen-presenting capability via beta2-ARs. Here, we show that also BMDC express mRNA for beta1-, beta2-, alpha2(A)- and alpha2(C)-ARs. Inhibition of IL-12 is mediated by both beta2- and alpha2(A)-ARs, while stimulation of IL-10 by beta2-ARs only. In addition, LC migration, the contact hypersensitivity response (CHS) and production of IFN-gamma and IL-2 in draining lymph node cells is increased in mice treated topically with the beta2-AR antagonist ICI 118,551 during FITC sensitization. Activation of beta2-ARs in BMDC before adoptive transfer could reduce both migration and CHS response to FITC. Finally, preincubation of BMDC with LPS in presence of the specific beta2-AR agonist salbutamol impaired their chemotactic response to CCL19 and CCL21 and this effect was neutralized by anti-IL-10 mAb. We suggest that the physiological activation of beta2-ARs in DC (LC) results in stimulation of IL-10 which in turn restrains DC (LC) migration influencing antigen presentation and the consequent CHS response.


Subject(s)
Cell Movement/immunology , Cytokines/biosynthesis , Dermatitis, Contact/immunology , Dermatitis, Contact/metabolism , Langerhans Cells/immunology , Langerhans Cells/metabolism , Receptors, Adrenergic, beta-2/physiology , T-Lymphocytes, Helper-Inducer/immunology , Adoptive Transfer , Adrenergic beta-2 Receptor Agonists , Adrenergic beta-2 Receptor Antagonists , Adrenergic beta-Agonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Albuterol/pharmacology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Cell Differentiation/immunology , Cell Movement/drug effects , Cells, Cultured , Chemokine CCL19 , Chemokine CCL21 , Chemokines, CC/antagonists & inhibitors , Chemokines, CC/physiology , Female , Injections, Subcutaneous , Langerhans Cells/cytology , Langerhans Cells/transplantation , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Mice , Mice, Inbred BALB C , Propanolamines/pharmacology , RNA, Messenger/biosynthesis , Receptors, Adrenergic, beta-2/genetics , T-Lymphocytes, Helper-Inducer/metabolism
20.
J Neuroimmunol ; 129(1-2): 106-14, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12161026

ABSTRACT

The information gathered by dendritic cells (DC) during the innate immune response to a pathogen is determinant for the type of adaptive response. Here we show that short-term (3 h) exposure of bone marrow-derived DC to norepinephrine (NE), at the beginning of lipopolysaccharide (LPS) or keyhole limpet hemocyanin (KLH) stimulation hampers IL-12 production and increases IL-10 release. The NE effect was mediated by both beta- and alpha2-adrenergic receptors. The capacity of NE-exposed DC to produce IL-12 upon CD40 cross-linking as well as to stimulate allogeneic T-helper (Th) lymphocytes was reduced. Adoptive transfer of NE-exposed DC induced a Th2 slanted response in vivo. Thus, a brief NE exposure of antigen-stimulated DC seems to limit their Th1 polarizing properties. Noteworthy, the ganglionic blocker pentolinium administered in mice before skin sensitization with fluoroscein isothiocyanate (FITC) could increase the Th1-type response in the draining lymph nodes. Our results suggest that the extent of Th differentiation in the response to an antigen might be influenced by the local sympathetic nervous activity in the early phase of dendritic cell stimulation.


Subject(s)
Bone Marrow/innervation , Cell Differentiation/immunology , Cytokines/biosynthesis , Dendritic Cells/immunology , Immunologic Surveillance/immunology , Nordefrin/metabolism , T-Lymphocytes, Helper-Inducer/immunology , Animals , Antigen Presentation/drug effects , Antigen Presentation/immunology , Bone Marrow/immunology , Bone Marrow/metabolism , Cell Differentiation/drug effects , Chemotaxis, Leukocyte/drug effects , Chemotaxis, Leukocyte/immunology , Cytokines/drug effects , Cytokines/immunology , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Drug Administration Schedule , Female , Hemocyanins/pharmacology , Immunologic Surveillance/drug effects , Interferon-gamma/biosynthesis , Interferon-gamma/immunology , Interleukin-10/biosynthesis , Interleukin-10/immunology , Interleukin-12/biosynthesis , Interleukin-12/immunology , Interleukin-4/biosynthesis , Interleukin-4/immunology , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Nordefrin/pharmacology , Sympathetic Fibers, Postganglionic/immunology , Sympathetic Fibers, Postganglionic/metabolism , T-Lymphocytes, Helper-Inducer/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...